Samarth Hegde

5.5k total citations · 2 hit papers
13 papers, 2.0k citations indexed

About

Samarth Hegde is a scholar working on Oncology, Immunology and Immunology and Allergy. According to data from OpenAlex, Samarth Hegde has authored 13 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 3 papers in Immunology and Allergy. Recurrent topics in Samarth Hegde's work include Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Samarth Hegde is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Samarth Hegde collaborates with scholars based in United States, India and Austria. Samarth Hegde's co-authors include Miriam Mérad, David G. DeNardo, Andrew M. Leader, Hong Jiang, Brett L. Knolhoff, William G. Hawkins, Jonathan A. Pachter, John M. Herndon, Yu Zhu and Irina M. Shapiro and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Immunity.

In The Last Decade

Samarth Hegde

13 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

2016 754 citations Hong Jiang, Samarth Hegde et al. Nature Medicine profile →
MDSC: Markers, development, states, and unaddressed complexity

2021 442 citations Samarth Hegde, Andrew M. Leader et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samarth Hegde United States	11	1.3k	1.1k	542	290	160	13	2.0k
Veronica Steri United States	17	827 0.6×	705 0.7×	796 1.5×	215 0.7×	122 0.8×	34	1.8k
Klara Balint United States	15	1.4k 1.1×	1.4k 1.3×	1.2k 2.2×	454 1.6×	151 0.9×	20	2.7k
Malin Pedersen United Kingdom	22	1.1k 0.8×	673 0.6×	1.3k 2.3×	293 1.0×	198 1.2×	37	2.4k
Chahrazade Kantari‐Mimoun France	10	680 0.5×	766 0.7×	388 0.7×	186 0.6×	92 0.6×	11	1.3k
Elisabeth J. M. Huijbers Netherlands	19	486 0.4×	432 0.4×	697 1.3×	347 1.2×	98 0.6×	35	1.3k
Mark B. Meads United States	12	753 0.6×	307 0.3×	771 1.4×	307 1.1×	140 0.9×	36	1.6k
Viia Valge-Archer United Kingdom	19	1.0k 0.8×	1.2k 1.1×	1.1k 2.0×	373 1.3×	82 0.5×	27	2.4k
Silvia Miotti Italy	30	824 0.6×	685 0.6×	1.1k 2.1×	242 0.8×	247 1.5×	59	2.4k
Ayuko Hoshino Japan	10	780 0.6×	400 0.4×	996 1.8×	641 2.2×	95 0.6×	23	1.8k
Nathan E. Reticker-Flynn United States	13	802 0.6×	826 0.8×	536 1.0×	146 0.5×	78 0.5×	24	1.5k

Countries citing papers authored by Samarth Hegde

Since Specialization

Citations

This map shows the geographic impact of Samarth Hegde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samarth Hegde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samarth Hegde more than expected).

Fields of papers citing papers by Samarth Hegde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samarth Hegde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samarth Hegde. The network helps show where Samarth Hegde may publish in the future.

Co-authorship network of co-authors of Samarth Hegde

This figure shows the co-authorship network connecting the top 25 collaborators of Samarth Hegde. A scholar is included among the top collaborators of Samarth Hegde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samarth Hegde. Samarth Hegde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Park, Matthew D., Meriem Belabed, Steven T. Chen, et al.. (2023). On the Biology and Therapeutic Modulation of Macrophages and Dendritic Cells in Cancer. 7(1). 291–311. 10 indexed citations

2.

Marron, Thomas U., Nicole A. Hall, Nelson M. LaMarche, et al.. (2022). A phase 1b/2 trial of dupilumab given in conjunction with PD-(L)1 blockade in the treatment of relapsed/refractory metastatic NSCLC.. Journal of Clinical Oncology. 40(16_suppl). TPS9139–TPS9139. 2 indexed citations

3.

Hegde, Samarth, Andrew M. Leader, & Miriam Mérad. (2021). MDSC: Markers, development, states, and unaddressed complexity. Immunity. 54(5). 875–884. 442 indexed citations breakdown →

4.

Hegde, Samarth, Brett H. Herzog, Chong Zuo, et al.. (2020). Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer. Cancer Cell. 37(3). 289–307.e9. 295 indexed citations

5.

Hegde, Samarth. (2020). Does asthma make COVID-19 worse?. Nature reviews. Immunology. 20(6). 352–352. 13 indexed citations

6.

Hegde, Samarth. (2020). Many paths to COVID-19 lymphocyte dysfunction. Nature reviews. Immunology. 20(7). 408–408. 1 indexed citations

7.

Jiang, Hong, Xiuting Liu, Brett L. Knolhoff, et al.. (2019). Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion. Gut. 69(1). 122–132. 101 indexed citations

8.

Panni, Roheena Z., John M. Herndon, Chong Zuo, et al.. (2019). Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies. Science Translational Medicine. 11(499). 145 indexed citations

9.

Jiang, Hong, Samarth Hegde, & David G. DeNardo. (2017). Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy. Cancer Immunology Immunotherapy. 66(8). 1037–1048. 170 indexed citations

10.

Hegde, Samarth, et al.. (2016). Sterile Inflammation Enhances ECM Degradation in Integrin β1 KO Embryonic Skin. Cell Reports. 16(12). 3334–3347. 26 indexed citations

11.

Jiang, Hong, Samarth Hegde, Brett L. Knolhoff, et al.. (2016). Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy. Nature Medicine. 22(8). 851–860. 754 indexed citations breakdown →

12.

Hegde, Samarth & S. Raghavan. (2013). A Skin-depth Analysis of Integrins: Role of the Integrin Network in Health and Disease. Cell Communication & Adhesion. 20(6). 155–169. 37 indexed citations

13.

Hosur, M.V., R. Chitra, Samarth Hegde, et al.. (2013). Low-barrier hydrogen bonds in proteins. Crystallography Reviews. 19(1). 3–50. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact